RenuTend suspension for injection for horses – EU/2/22/282/001 – Two batches
We wish to advise you that two batches of RenuTend suspension for injection for horses, EU/2/22/282/001 are being recalled with immediate effect.
This recall is going to veterinary level.
The reason for the recall is due to deviations in GMP manufacturing. This is a voluntary recall and there is no need to contact owners of horses that have been treated with these batches.
Veterinarians can download a copy of the veterinary recall letter at the bottom of this page.
Product information
- Authorisation holder
- Boehringer Ingelheim Animal Health UK Limited
- Authorisation number
- EU/2/22/282/001
- Serial or batch number and expiry date
-
Batch T36093/05, expiry June 2024
Batch T36105/04, expiry February 2025
- Human or veterinary medicine
- Veterinary
- Target audience
- Veterinary Surgeons
- Recall level
- Veterinary level
Actions to be taken
Veterinarians are requested to please perform the following actions:
- Please check your inventory and immediately quarantine any units of these batches which you have in your possession, or that are returned to you.
- Please complete the returns form attached to the recall letter detailing the number of units to be returned and return this form to Customer Services via email at CSServiceQueries.bra@boehringer-ingelheim.com
- The company's customer service team will contact you to arrange collection of the units.
Animal owners:
If you have this product in your possession and have any concerns, please contact your veterinary hospital.
In line with standard pharmacovigilance procedure for any veterinary medicinal product, should any horse treated with RenuTend suspension for injection for horses experience any adverse event, please contact vetenquiries@boehringer-ingelheim.com.